Genetic differences explain MS treatment variations
Multiple Sclerosis (MS) sufferers can puzzle medical professionals sometimes. Standard treatments that work on some just don't work on other. From a genetic standpoint, some genetic differences at play within patients may explain this, according to a new study out of Europe.Relapsing-remitting MS is the most common form of the disease, so international researchers extracted the DNA from those MS patients who had full symptom reduction after having used interferon therapy. It then collected DNA from those who also received the same type of therapy, but who suffered relapses after this therapy.
The differences discovered in the two groups pointed to specific genetic differences in the two MS groups. Customizing treatment per patient would be a end goal of medical professionals (compared to "blanket" treatments that are not as effective for some) -- this this new discovery fits squarely in that camp. Researchers wrote "in the absence of prognostic clinical, neuroradiological and/or immunological markers of response, the question remains who and when to treat when adverse effects, inconvenience and the cost of drugs are significant."
And, when insurance companies start balking at the price of treatment for those suffering from MS with valid insurance coverage, I suppose.

Sunlight's getting a lot of press lately, with emerging research that vitamin D is crucial for the prevention of certain diseases. Sun exposure is one of the easiest and most efficient ways to get vitamin D, but because sun exposure also brings with it the risk of skin cancer, getting enough but not too much is a balancing act.
Multiple Sclerosis (MS) is a chronic neurological disease of the central nervous system. One of the most prevalent symptoms of MS is difficulty with balance and walking. It's
When someone suffering from multiple sclerosis or Parkinson's walks, they may sometimes "freeze" or have difficulty following through with the motion. Health experts have known that patients' brains can be triggered to keep moving by placing an object in front of them, which helps send a new signal to the brain and gets the muscles moving again.
The symptoms of multiple sclerosis have been noted to ease for women during pregnancy, and scientists believe it's due to the hormone prolactin. In MS the human body attacks the myelin that surrounds nerves, and it's been thought that during pregnancy the immune system no longer attacks the myelin. Now, though, according to data published in the Journal of Neuroscience, it seems 










.jpg)







